PTJ
WGS icon

Paul Tudor Jones’s GeneDx Holdings WGS Stock Holding History

Paul Tudor Jones’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
15,400
+4,700
+44% +$267K ﹤0.01% 2382
2026
Q1 		$687K Buy
10,700
+3,400
+47% +$310K ﹤0.01% 2615
2025
Q4 		$949K Sell
7,300
-3,000
-29% -$412K ﹤0.01% 2313
2025
Q3 		$1.11M Sell
10,300
-13,200
-56% -$1.44M ﹤0.01% 2195
2025
Q2 		$2.17M Buy
23,500
+21,100
+879% +$1.66M ﹤0.01% 1608
2025
Q1 		$213K Buy
+2,400
New +$208K ﹤0.01% 2833

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Paul Tudor Jones's WGS Position: Q2 2026 in Review

Paul Tudor Jones increased its GeneDx Holdings (WGS) stake by 225% in Q2 2026, buying an estimated $4.28M and bringing the position to 108,839 shares worth $7.47M. The position accounts for 0.01% of the portfolio, ranked #1019.

Paul Tudor Jones first reported a position in WGS in Q3 2021 and has held it in 10 quarters since. The position peaked at $7.83M in Q4 2024. 222 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Paul Tudor Jones held 108,839 shares of GeneDx Holdings worth $7.47M as of Q2 2026.
  • Paul Tudor Jones bought 75,299 GeneDx Holdings shares in Q2 2026, an estimated $4.28M.
  • GeneDx Holdings made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1019 holding.
  • Paul Tudor Jones first reported a position in GeneDx Holdings in Q3 2021 and has held it in 10 quarters since.
  • Paul Tudor Jones's GeneDx Holdings position peaked at $7.83M in Q4 2024.
  • 222 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.